ABBV — AbbVie Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About AbbVie Inc

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis f… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$213.12
Market Cap$378.98B
Float1.76B
Shares Outstanding1.77B
P/E (Forward)15.04
P/E (TTM)105.15
Price/Sales (TTM)6.03
vs. Analyst Target+18.7% to analyst PT
Profit Margin5.79%
Operating Margin (TTM)32.16%
Revenue (TTM)$62.82B
Earnings Growth (YoY)-46.20%
Dividend Rate6.9%
Analyst Target Price$252.90 (28 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $45.80B $4.62B $30.42B $12.32B
2021 $56.20B $11.54B $38.75B $23.93B
2022 $58.05B $11.84B $40.64B $24.17B
2023 $54.32B $4.86B $33.90B $17.17B
2024 $56.33B $4.28B $39.43B $14.91B
2025 $61.16B $4.23B $42.96B $17.63B

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $15.42B $938M
Sep 2025 $15.78B $186M
Dec 2025 $16.62B $1.82B
Mar 2026 $15.00B $699M

Ownership & Float

Insider Ownership0.1%
Institutional Ownership77.0%
Short Float1.2%
% of All Funds Holding46.20%
Number of Funds Holding3,797

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$208.06Near-term / short-term trend
Weekly40-Week SMA$219.99Medium-term trend
Weekly80-Week SMA$204.48Cyclical trend (business cycle)
Weekly200-Week SMA$177.42Secular trend (multi-year)
Monthly10-Month SMA$221.32Near-term monthly trend
Monthly20-Month SMA$206.80Medium-term monthly trend
Monthly40-Month SMA$183.86Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$233.00 resistance 1.30x 1 months ago
$233.00 resistance 1.03x 6 months ago
$160.00 support 1.04x 22 months ago

Historical Earnings Reactions (54 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.01% -0.01% 44.44% 3.44% -1.53%
1 Day -0.19% -0.33% 42.59% 6.43% -7.28%
1 Week -0.26% 0.14% 51.85% 12.73% -13.19%
2 Weeks 0.42% 0.39% 51.85% 15.58% -15.61%
1 Month 0.81% 0.28% 50.00% 23.08% -14.82%

Next earnings: July 18, 2026 (51 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan-2.6%30.8%13
Feb3.9%85.7%14
Mar0.1%71.4%14
Apr0.7%57.1%14
May0.2%61.5%13
Jun0.9%46.2%13
Jul1.2%53.8%13
Aug0.7%53.8%13
Sep1.5%53.8%13
Oct0.7%61.5%13
Nov6.4%76.9%13
Dec2.6%69.2%13

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.00% 53.4% 631
Tuesday 0.01% 50.9% 694
Wednesday 0.10% 54.3% 689
Thursday 0.06% 52.4% 677
Friday 0.16% 56.1% 676

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 77.0%

Insider Transactions — Smart Summary

Total insider ownership: 0.1%

12-Month Insider Activity Summary

Total Filings5
Net Value-$19.0M
Net Shares Change-52,043
% of Float-0.0%
C-Suite Filings5
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Siatis Perry C EVP, GC AND SECRETARY -$9.1M 2 N/A
SALEKI-GERHARDT AZITA EVP, CHIEF OPERATIONS OFFICER -$6.1M 1 1 sell
Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER -$2.6M 1 1 sell
Purdue David Ryan SVP, Controller -$1.2M 1 1 sell

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-03-06 Purdue David Ryan SVP, Controller -$1.2M Transaction at $233.56, now -8.8%
2025-08-07 Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER -$2.6M Transaction at $198.51, now +7.4%
2026-03-03 Siatis Perry C EVP, GC AND SECRETARY -$7.8M Transaction at $233.23, now -8.6%
2025-08-14 SALEKI-GERHARDT AZITA EVP, CHIEF OPERATIONS OFFICER -$6.1M Transaction at $126.64, now +68.3%
2026-02-27 Siatis Perry C EVP, GC AND SECRETARY -$1.3M Transaction at $201.31, now +5.9%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for AbbVie Inc (ABBV) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for ABBV on Trend Edge →